
|Videos|November 30, 2022
The Importance of Molecular Testing in Metastatic Colorectal Cancer
Dr Tanios Bekaii-Saab explains the rarity of HER2+ metastatic colorectal cancer and how his clinical practice detects HER2 alterations.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Pembrolizumab/EV Combo in Muscle Invasive Bladder Cancer
2
FDA Approves Subcutaneous Isatuximab in Multiple Myeloma
3
EMA’s Review of Daraxonrasib in PDAC Accelerated Under Phased Review Process
4
HARMONi-6: Evaluating the Safety and Generalizability of Ivonescimab in NSCLC
5





















































































